At a glance
ClinicalIndex Comparison RecordN/ACompleted· 37 enrolled
Drug / intervention
F&P Saturndevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Development Study to Evaluate a Nasal Mask for the Treatment of Obstructive Sleep Apnea
In Brief
A clinical study evaluating F&P Saturn for Obstructive Sleep Apnea. Completed, enrolled 37 participants across 1 site.
Detailed Summary
This investigation is designed to evaluate the comfort, ease of use and performance of a trial nasal mask for the treatment of Obstructive Sleep Apnea (OSA) in the home environment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 2017
Enrollment StartApr 2017
Primary CompletionMay 2017
Study CompletionSep 2017
TodayJul 2026
First PostedApr 21, 2017
Enrollment StartApr 24, 2017
Primary CompletionMay 26, 2017
Study CompletionSep 30, 2017
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 9.2 years ago
Interventions
F&P Saturndevice
Participants will be placed on this arm for a total of 14 ± 5 days from Visit 2. Participants will be using the trial nasal mask during this treatment arm.